SCHEMBL20019720

SCHEMBL20019720

CN[C@@H]1CN(Cc2ccccc2)CC[C@H]1C

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACHE P22303 9/20 0.57
BCHE P06276 9/20 0.52
BACE1 P56817 8/20 0.52
ALDH1A1 P00352 1/20 0.51
SCN4A P35499 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
CCR3 P51677 1/20 0.47
SIGMAR1 Q99720 1/20 0.46
CXCR4 P61073 1/20 0.46
DRD2 P14416 1/20 0.45
DRD4 P21917 1/20 0.45
DRD3 P35462 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1993388 1.00 ACHE (0.57) ACHEBCHEBACE1ALDH1A1SCN4A
SCHEMBL20019719 1.00 ACHE (0.57) ACHEBCHEBACE1ALDH1A1SCN4A
SCHEMBL14018259 1.00 ACHE (0.57) ACHEBCHEBACE1ALDH1A1SCN4A
SCHEMBL12395260 1.00 ACHE (0.57) ACHEBCHEBACE1ALDH1A1SCN4A
SCHEMBL690845 1.00 ACHE (0.57) ACHEBCHEBACE1ALDH1A1SCN4A
SCHEMBL352022 1.00 ACHE (0.57) ACHEBCHEBACE1ALDH1A1SCN4A
Hydrochloric Acid SCHEMBL20597421 0.98 ACHE (0.55) ACHEBCHEBACE1ALDH1A1SCN4A
Hydrochloric Acid SCHEMBL22500017 0.98 ACHE (0.55) ACHEBCHEBACE1ALDH1A1SCN4A
Hydrochloric Acid SCHEMBL2148084 0.98 ACHE (0.55) ACHEBCHEBACE1ALDH1A1SCN4A
Hydrochloric Acid SCHEMBL1373413 0.98 ACHE (0.55) ACHEBCHEBACE1ALDH1A1SCN4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113125587-B Tofacitinib intermediate and detection method of enantiomer thereof 成都百裕制药股份有限公司 2022-05-24 CN disclosed
CN-113549075-A Synthesis method of tofacitinib citrate diastereoisomer impurity 合肥华方医药科技有限公司 2021-10-26 CN disclosed
WO-2018060512-A1 PROCESS FOR PREPARING CHIRAL AMINES PATHEON AUSTRIA GMBH & CO KG (AT) 2018-04-05 WO disclosed
EP-3301087-A1 PROCESS FOR PREPARING CHIRAL AMINES DPx Fine Chemicals Austria GmbH & Co KG (AT) 2018-04-04 EP disclosed